Early MRI and outcomes of untreated patients with mild or improving ischemic stroke

被引:207
作者
Rajajee, V. [1 ]
Kidwell, C. [1 ]
Starkman, S. [1 ]
Ovbiagele, B. [1 ]
Alger, J. R. [1 ]
Villablanca, P. [1 ]
Vinuela, F. [1 ]
Duckwiler, G. [1 ]
Jahan, R. [1 ]
Fredieu, A. [1 ]
Suzuki, S. [1 ]
Saver, J. L. [1 ]
机构
[1] Univ Calif Los Angeles, Ctr Med, Los Angeles, CA 90024 USA
关键词
D O I
10.1212/01.wnl.0000237520.88777.71
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the frequency of early neurologic deterioration with infarct expansion (ENDIE) and poor outcomes among ischemic stroke patients not treated with reperfusion therapies because of rapidly improving or mild symptoms (RIMS) and to study the predictive value of hyperacute MRI in these patients. Methods: We identified consecutive patients with symptoms of acute stroke undergoing multimodal MRI within 6 hours of onset without evidence of hemorrhage on imaging. Medical records were reviewed for evidence of early neurologic deterioration within 48 hours. All deteriorating patients had repeat MRI to ascertain causes of worsening. Poor outcome was defined as a discharge modified Rankin Scale (mRS) score of >= 3. Results: We identified 74 patients with stroke symptoms <= 6 hours from onset. Forty had RIMS, and 39 did not receive reperfusion therapies because of RIMS. Among these 39, 4 experienced ENDIE, and 8 were discharged with mRS score of >= 3. Eight of the 39 patients had large-vessel occlusions on MR angiography. Three of 8 patients with large-vessel occlusion as against only one of 31 patients without occlusion had ENDIE (odds ratio [OR] 18, 95% CI 1.6 to 209, p = 0.02). Four of 8 patients with large-vessel occlusion as against 4 of 31 patients without occlusion had a discharge mRS score of >= 3 (OR 7, 95% CI 1.2 to 38, p = 0.04). Conclusions: About 10% of patients eligible for acute reperfusion therapy excluded on the basis of mild or rapidly improving symptoms show early neurologic deterioration with infarct expansion within 48 hours, and about 20% show poor outcome at discharge. Persisting large-vessel occlusion substantially increases the risk of early worsening and poor functional outcome.
引用
收藏
页码:980 / 984
页数:5
相关论文
共 13 条
[1]   Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association [J].
Adams, HP ;
Adams, RJ ;
Brott, T ;
del Zoppo, GJ ;
Furlan, A ;
Goldstein, LB ;
Grubb, RL ;
Higashida, R ;
Kidwell, C ;
Kwiatkowski, TG ;
Marler, JR ;
Hademenos, GJ .
STROKE, 2003, 34 (04) :1056-1083
[2]   Deterioration following spontaneous improvement - Sonographic findings in patients with acutely resolving symptoms of cerebral ischemia [J].
Alexandrov, AV ;
Felberg, RA ;
Demchuk, AM ;
Christou, I ;
Burgin, WS ;
Malkoff, M ;
Wojner, AW ;
Grotta, JC .
STROKE, 2000, 31 (04) :915-919
[3]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[4]   SPONTANEOUS IMPROVEMENT AFTER ACUTE ISCHEMIC STROKE - A PILOT-STUDY [J].
BILLER, J ;
LOVE, BB ;
MARSH, EE ;
JONES, MP ;
KNEPPER, LE ;
JIANG, D ;
ADAMS, HP ;
GORDON, DL .
STROKE, 1990, 21 (07) :1008-1012
[5]   Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Experience [J].
Broderick, JP ;
Brott, T ;
DeGraba, T ;
Fagan, SC ;
Frankel, MR ;
Grotta, JC ;
Haley, EC ;
Hamilton, S ;
Kwiatkowski, T ;
Levine, SR ;
Lewandowski, CA ;
Lin, Y ;
Libman, R ;
Lu, M ;
Lyden, P ;
Marler, JR ;
Morgenstern, L ;
Patel, S ;
Sanders, C ;
Tilley, BC .
ANNALS OF EMERGENCY MEDICINE, 2005, 46 (03) :243-252
[6]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[7]   Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial [J].
Grotta, JC ;
Welch, KMA ;
Fagan, SC ;
Lu, M ;
Frankel, MR ;
Brott, T ;
Levine, SR ;
Lyden, PD .
STROKE, 2001, 32 (03) :661-668
[8]   Utilization of intravenous tissue plasminogen activator for acute ischemic stroke [J].
Katzan, IL ;
Hammer, MD ;
Hixson, ED ;
Furlan, AJ ;
Abou-Chebl, A ;
Nadzam, DM .
ARCHIVES OF NEUROLOGY, 2004, 61 (03) :346-350
[9]   Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke - A population-based study [J].
Kleindorfer, D ;
Kissela, B ;
Schneider, A ;
Woo, D ;
Khoury, J ;
Miller, R ;
Alwell, K ;
Gebel, J ;
Szaflarski, J ;
Pancioli, A ;
Jauch, E ;
Moomaw, C ;
Shukla, R ;
Broderick, JP .
STROKE, 2004, 35 (02) :E27-E29
[10]  
Rajajee V, 2004, STROKE, V35, P262